Zymeworks Inc.

ZYME

ZYME has 8 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 8 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Jan 12 and filed Jan 13. The most active filer was EcoR1 Capital, LLC with 12 filings.

Add to watchlist

Filings, ttm

0 buys · 8 sells

Traders, ttm

4 insiders

Volume, ttmiDollar value disclosed in the window

$4.7M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Jan 12

Filed Jan 13

ADViAverage daily dollar volume

–

not on file

Share price · 12M

$24.97 (+51.1%)

Adjusted for splits and dividends.

Volume by month

Buys $57.9M Sells $6.0M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

EL EcoR1 Capital, LLC Director 12 filings KG Kenneth Galbraith Chair & CEO 4 filings PM Paul Andrew Moore Chief Scientific Officer 3 filings JS Jeffrey T L Smith EVP & Chief Medical Officer 3 filings ON Oleg Nodelman Director 2 filings MH Mark Hollywood EVP & Chief Operating Officer 1 filing

Recent filings

Mark HollywoodSALE EVP & Chief Operating Officer $139K
6,120 sh × $22.67
Exec Jan 12
Filed Jan 13 · 5:30 PM ET Kenneth GalbraithSALE Chair & CEO $690K
30,424 sh × $22.67
Exec Jan 12
Filed Jan 12 · 5:30 PM ET Paul Andrew MooreSALE Chief Scientific Officer $217K
9,560 sh × $22.67
Exec Jan 12
Filed Jan 12 · 5:30 PM ET Jeffrey T L SmithSALE EVP & Chief Medical Officer $211K
9,310 sh × $22.67
Exec Jan 12
Filed Jan 12 · 5:30 PM ET Paul Andrew MooreSALE Chief Scientific Officer $505K
20,110 sh across 2 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Kenneth GalbraithSALE Chair & CEO $1.4M
54,343 sh across 2 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Jeffrey T L SmithSALE EVP & Chief Medical Officer $265K
10,538 sh × $25.10
Exec Jan 5
Filed Jan 5 · 5:30 PM ET Kenneth GalbraithSALE Chair & CEO $1.3M
47,528 sh × $27.02
Exec Dec 22 2025
Filed Dec 22 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $566K
49,502 sh × $11.43
Exec May 15 2025
Filed May 19 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $1.5M
128,713 sh across 2 lots
Exec Apr 16 2025
Filed Apr 18 2025 · 5:30 PM ET Oleg NodelmanPURCHASE Director $3.6M
317,208 sh across 2 lots
Exec Apr 3 2025
Filed Apr 7 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $1.4M
123,018 sh across 2 lots
Exec Apr 1 2025
Filed Apr 2 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $1.2M
97,349 sh across 2 lots
Exec Mar 25 2025
Filed Mar 27 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $1.6M
127,198 sh across 3 lots
Exec Mar 20 2025
Filed Mar 24 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $2.9M
228,463 sh across 3 lots
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET Oleg NodelmanPURCHASE Director $13.1M
1,081,980 sh across 3 lots
Exec Mar 11 2025
Filed Mar 13 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $2.0M
141,429 sh across 2 lots
Exec Jan 16 2025
Filed Jan 21 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $2.3M
167,654 sh across 3 lots
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $3.0M
225,119 sh across 2 lots
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET Jeffrey T L SmithSALE EVP & Chief Medical Officer $166K
11,110 sh × $14.92
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET Kenneth GalbraithSALE Chair & CEO $855K
57,291 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET Paul Andrew MooreSALE Chief Scientific Officer $316K
21,200 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $5.3M
363,369 sh across 3 lots
Exec Dec 30 2024
Filed Jan 2 2025 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $1.9M
130,309 sh across 3 lots
Exec Dec 24 2024
Filed Dec 27 2024 · 5:30 PM ET EcoR1 Capital, LLCPURCHASE Director $17.5M
1,254,808 sh across 3 lots
Exec Dec 19 2024
Filed Dec 26 2024 · 5:30 PM ET †